News

Sep 29
Berkshire Hathaway, Lloyds of London, Munich Re cover much of Florida market impacted by Hurricane Ian

Berkshire Hathaway’s BRK.A, -1.02% General Re, Lloyds of London, Munich Re, Swiss Re AG, and Allianz Group ALV, -0.90% lead the list of top reinsurers of Florida-only property insurers in assumed premiums, Moody’s said Thursday in a research note. Property and casualty insurers such as Universal P&C, Citizens Property Insurance Corp., First Protective and American […]

Sep 29
Brookfield Renewable Partners buys pair of renewable portfolios for up to $2 bln investment

Brookfield Renewable Partners LP BP, -0.62% BEPC, -2.29% BEPC, -1.76% said Thursday it will invest up to $2 billion in two renewable energy portfolios in the U.S. Brookfield Renewable will pay $1 billion and invest an additional $270 million to acquire Scout Clean Energy, which owns more than 1,200 MW of operating wind assets and […]

Sep 29
Alibaba stock drops after J.P. Morgan cuts price target, turns cautious on revenue outlook

Shares of Alibaba Group Holding Ltd. BABA, -3.33% dropped 2.8% in premarket trading Thursday, after J.P. Morgan analyst Alex Yao said he turned “cautious” on the China-based e-commerce giant’s fiscal second-quarter revenue outlook, citing “weak China consumption.” Yao reiterated the overweight rating on the stock but cut the price target to $135 from $145.Yao expects […]

Sep 29
Aluminum prices, Alcoa jump on report LME could ban Russian metal

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein.

Sep 29
Axcella’s stock is up 10% after sharing new data for its NASH treatment

Shares of Axcella Therapeutics Inc. AXLA, +7.24% gained 10.9% in premarket trading on Thursday after the biotech said its experimental treatment for nonalcoholic steatohepatitis (NASH) showed statistically significant improvement in liver stiffness at 24 weeks. The Phase 2b trial is ongoing. The company expects to have topline data from the 48-week mark by the first […]

Sep 29
Worthington Industries to separate into two publicly-traded companies in 2024

Worthington Industries Inc. WOR, -5.73% said Thursday its board approved a plan to separate the company’s steel processing business into a new public company, through a distribution of stock in the business. The Columbus, Ohio-based industrial company said the steel processing separation is expected to be tax-free to shareholders when it takes place as expected […]